Jan 8 (Reuters) - Flexion Therapeutics Inc:
* FLEXION THERAPEUTICS ANNOUNCES INITIAL DATA FROM CLINICAL TRIAL EVALUATING REPEAT ADMINISTRATION OF ZILRETTAâ„¢ (TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION)
* FLEXION THERAPEUTICS - ZILRETTA FULL STUDY RESULTS EXPECTED IN Q3 2018 Source text for Eikon: Further company coverage:
 